These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 8878282

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA, Horne D, Briganti S, Rodis JF, Clive JM.
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [Abstract] [Full Text] [Related]

  • 4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC, Canda MT, Ahmet N, Arda S, Süt N, Varol FG.
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [Abstract] [Full Text] [Related]

  • 10. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
    Benn PA, Craffey A, Horne D, Ramsdell L, Rodis JF.
    J Matern Fetal Med; 2000 Jan; 9(3):165-9. PubMed ID: 10914624
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The detection of non-immune hydrops through second-trimester maternal serum screening.
    Saller DN, Canick JA, Oyer CE.
    Prenat Diagn; 1996 May; 16(5):431-5. PubMed ID: 8844001
    [Abstract] [Full Text] [Related]

  • 14. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 15. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
    Huang T, Hoffman B, Meschino W, Kingdom J, Okun N.
    Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
    [Abstract] [Full Text] [Related]

  • 16. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects.
    Saller DN, Canick JA, Palomaki GE, Knight GJ, Haddow JE.
    Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fetal gender impact on multiple-marker screening results.
    Bazzett LB, Yaron Y, O'Brien JE, Critchfield G, Kramer RL, Ayoub M, Johnson MP, Evans MI.
    Am J Med Genet; 1998 Apr 13; 76(5):369-71. PubMed ID: 9556293
    [Abstract] [Full Text] [Related]

  • 20. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications.
    Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M.
    Obstet Gynecol; 1992 Jul 13; 80(1):83-6. PubMed ID: 1603504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.